New Weight Loss Drug Shows Promising Results
Orexigen Therapeutics Inc. reports that the a mid-stage trial of Empatic met its goal of demonstrating significant weight loss.
This news comes at a great time. America is getting bigger by the day; roughly two-thirds of adults in the United States are overweight, and almost one-third are obese.
Today, ABC News reported
An ongoing giant study of American nurses showed that only about 10 percent who made it to age 70 could be considered in top shape. Women who steadily gained weight from age 18 on ended up in the worst shape, the researchers said.
Most had some kind of physical or mental limitation, and more than a third had both chronic diseases and also mental or physical limitations.
Currently there are only a few options for weight loss aids deemed safe by the FDA: Meridia, Xenical, and Alli.
The good news is that results from the preliminary trails on Empatic look promising. Orexigen said
the 729-patient trial found that 60.4 percent of obese people given the highest dose of the drug lost at least 5 percent of their body weight, compared with 14.7 percent of patients given a placebo.
The 24-week trial also found that patients treated with Empatic had mean weight loss of 7.5 percent, compared with 1.4 percent for the placebo group — a percentage point difference of 6.1.
Empatic must still receive final approval by the FDA, but early estimates have it ready for market in 12 to 18 months.
Tweet
January 7th, 2010 at 2:40 pm
However promising this may or may not look, it looks like it will probably not be available for probably at least 2-3 years from now. But the same company is also working on Contrave which it plans on filing to the FDA very soon here.